Cognitive impairment with Type 2 Diabetes Mellitus among community-dwelling older adults in Chile: Prevalence, risk factors and cognitive characteristics

被引:1
|
作者
Bozanic, Agnieszka [1 ]
Toro, Pablo [2 ,3 ]
Bello-Lepe, Sebastian [4 ]
Hurtado-Oliva, Javier [5 ]
Beyle, Christian [6 ]
Valdes, Catalina [7 ]
Formiga, Francesc [8 ]
机构
[1] Univ Andres Bello, Fac Educ & Ciencias Sociales, Vina Del Mar, Chile
[2] Pontificia Univ Catolica Chile, Fac Med, Dept Psychiat, Santiago, Chile
[3] Pontificia Univ Catolica Chile, Adv Ctr Chron Dis, Santiago, Chile
[4] Valparaiso Univ, Sch Speech Therapy, Vina Del Mar, Chile
[5] Univ Groningen, Univ Med Ctr Groningen, Dept Otorhinolaryngol Head & Neck Surg, Groningen, Netherlands
[6] Univ Catolica Temuco, Psychol Dept, Temuco, Chile
[7] Univ Los Lagos, Dept Hlth, Osorno, Chile
[8] Hosp Univ Bellvitge, Geriatr Unit, Internal Med, IDIBELL, Barcelona, Spain
来源
FRONTIERS IN HUMAN NEUROSCIENCE | 2023年 / 16卷
关键词
Type 2 Diabetes Mellitus; dementia; Mild Cognitive Impairment; prevalence; cross-sectional study; PROJECT NORMS; METAANALYSIS; DYSFUNCTION; POPULATION; PREDICTORS; DEMENTIA; NUMBER;
D O I
10.3389/fnhum.2022.1070611
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
IntroductionThe aim of this study is to determine prevalence and risk factors of Cognitive Impairment (CI) and its association with Type 2 Diabetes Mellitus (T2DM) in subjects aged 65 years and above. Additionally, we attempt to provide a cognitive profile for T2DM group. MethodologyA cross-sectional analytical study to assess CI was carried out. We evaluated a sample of community-dwelling residents from Chile. All participants underwent a general interview, lifestyle questionnaires and a comprehensive neuropsychological battery. Regression analyses were performed to evaluate risk of CI with T2DM and influencing factors. Results between groups in the different domains of the neuropsychological assessment were compared by Student's t-tests and MANOVA. ResultsAmong all 358 subjects, overall T2DM prevalence were 17.3%. The prevalence of CI was higher in T2DM group compared to the healthy participants (30.7%, p < 0.001). The risk of CI was 2.8 times higher in older people with T2DM compared to older people without the diagnosis. Multiple regression analysis, adjusted for age and gender, demonstrated that age, education, presence of dyslipidemia, and T2DM duration were the predictor variables significantly associated with CI. T2DM group performed worse on global cognitive performance, attention, language, verbal memory, visual memory, visual constructional ability, and executive function. After adjusting for significant covariates from multiple regression analysis, a relationship between "cognition" and T2DM is still observed. Amnesic multi-domain impairment was the specific cognitive identified pattern for T2DM group. ConclusionThe present study confirms the high prevalence of CI with T2DM among Chilean older adults in a community-based population. T2DM is significantly associated with a higher risk of CI, and age, education, presence of dyslipidemia, and duration of T2DM are risk factors. T2DM patients with CI are impaired in multiple cognitive domains, even after adjusting covariables, resulting in an amnesic multi-domain cognitive profile.
引用
收藏
页数:9
相关论文
共 50 条
  • [31] Association between physical activity and mild cognitive impairment in community-dwelling older adults: Depression as a mediator
    Liu, Xinya
    Jiang, Yihua
    Peng, Wenjia
    Wang, Meng
    Chen, Xiaoli
    Li, Mengying
    Ruan, Ye
    Sun, Shuangyuan
    Yang, Tingting
    Yang, Yinghua
    Yan, Fei
    Wang, Feng
    Wang, Ying
    FRONTIERS IN AGING NEUROSCIENCE, 2022, 14
  • [32] Risk factors and metabolomics of mild cognitive impairment in type 2 diabetes mellitus
    Luo, Tao
    Jiang, Xiao
    Xu, Ning
    Zhao, Xinyu
    Xie, Xingjie
    Xia, Xiuwen
    Bian, XiaoLong
    Liu, Haixia
    FRONTIERS IN MOLECULAR BIOSCIENCES, 2024, 11
  • [33] The association between leisure activity patterns and the prevalence of mild cognitive impairment in community-dwelling older adults
    Zhang, Yuanyuan
    Yang, Xinxin
    Guo, Linlin
    Xu, Xinyi
    Chen, Bingyu
    Ma, Xiaowei
    Li, Yan
    FRONTIERS IN PSYCHOLOGY, 2023, 13
  • [34] Cognitive Change Checklist: Psychometric Characteristics in Community-Dwelling Older Adults
    Schinka, John A.
    Robinson, Diane C.
    Mills, Whitney L.
    Brown, Lisa M.
    AMERICAN JOURNAL OF GERIATRIC PSYCHIATRY, 2012, 20 (12): : 1070 - 1074
  • [35] Olfactory dysfunction is associated with mild cognitive impairment in community-dwelling older adults
    Yap, Ai Che
    Mahendran, Rathi
    Kua, Ee Heok
    Zhou, Weibiao
    Wang, De Yun
    FRONTIERS IN AGING NEUROSCIENCE, 2022, 14
  • [36] Correlates of Mild Cognitive Impairment of Community-Dwelling Older Adults in Wuhan, China
    Liu, Xiaojun
    Yin, Xiao
    Tan, Anran
    He, Meikun
    Jiang, Dongdong
    Hou, Yitan
    Lu, Yuanan
    Mao, Zongfu
    INTERNATIONAL JOURNAL OF ENVIRONMENTAL RESEARCH AND PUBLIC HEALTH, 2018, 15 (12)
  • [37] The APOE ε4 Allele Is Associated with Incident Mild Cognitive Impairment among Community-Dwelling Older Persons
    Boyle, Patricia A.
    Buchman, Aron S.
    Wilson, Robert S.
    Kelly, Jeremiah F.
    Bennett, David A.
    NEUROEPIDEMIOLOGY, 2010, 34 (01) : 43 - 49
  • [38] Association of Dynapenia, Sarcopenia, and Cognitive Impairment Among Community-Dwelling Older Taiwanese
    Huang, Chung-Yu
    Hwang, An-Chun
    Liu, Li-Kuo
    Lee, Wei-Ju
    Chen, Liang-Yu
    Peng, Li-Ning
    Lin, Ming-Hsien
    Chen, Liang-Kung
    REJUVENATION RESEARCH, 2016, 19 (01) : 71 - 78
  • [39] Oral frailty as a risk factor for mild cognitive impairment in community-dwelling older adults: Kashiwa study
    Nagatani, Miyuki
    Tanaka, Tomoki
    Son, Bo-Kyung
    Kawamura, Jun
    Tagomori, Junko
    Hirano, Hirohiko
    Shirobe, Maki
    Iijima, Katsuya
    EXPERIMENTAL GERONTOLOGY, 2023, 172
  • [40] Risk factors for cognitive impairment in older people with diabetes: a community-based study
    Xiu, Shuangling
    Liao, Qiuju
    Sun, Lina
    Chan, Piu
    THERAPEUTIC ADVANCES IN ENDOCRINOLOGY AND METABOLISM, 2019, 10